Financial Year |
March 31 2023 |
Monetary Funds |
1,076,454,694.13 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
179,146,435.91 |
Advances to Suppliers |
68,931,201.17 |
Other Receivables |
50,903,989.75 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
406,580,949.85 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
37,616,285.25 |
Total Current Assets |
1,831,722,450.50 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
6,917,238.08 |
Investment Properties |
24,444,064.11 |
Fixed Assetes |
725,801,328.14 |
Under-construction Projects |
76,558,950.87 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
55,648,962.10 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
15,678,541.58 |
Deferred Income Tax Assets |
118,312,778.67 |
Other Non-Current Assets |
10,519,382.82 |
Sub-Total of Non-Current Assets |
1,050,570,131.19 |
Total Assets |
2,882,292,581.69 |
Short-Term Loans |
162,250,464.34 |
Trading Financial liabilities |
-- |
Notes Payable |
1,075,498.98 |
Accounts Payable |
120,550,318.34 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
11,044,735.32 |
Taxes Payable |
8,940,105.46 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
94,568,308.56 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
48,735,130.46 |
Other Current Liabilities |
5,575,030.46 |
Sub-Total of Current Liabilities |
487,026,883.13 |
Long-term Loans |
153,825,641.01 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
6,365,826.51 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
613,605,010.08 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
829,233,748.21 |
Total Liabilities |
1,316,260,631.34 |
Paid-In Capital(Or Share Stock) |
1,835,468,461.00 |
Capital Surplus |
3,105,848,427.17 |
Surplus Reserve |
60,236,974.24 |
LESS:Treasury Stock |
19,504,392.25 |
Undistributed Profits |
-3,409,579,130.10 |
Minority Stockholder's Interest |
2,751,920.74 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,563,280,029.61 |
Owner's Equity(Stockholder's Equity) |
1,566,031,950.35 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,882,292,581.69 |